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ABASTRACT 
 
In the present work, a reverse transcriptase polymerase chain 
reaction (RT-PCR) protocol was carried out to detect  African horse 
sickness virus (AHSV) RNA in vero cell culture. 
The nine serotypes of African horse sickness virus were used in 
this study . All these serotypes were propagated in vero cell culture. 
RNAs were extracted from these serotypes and then, they were 
detected by the described RT-PCR assay, using primers derived from 
segment 3 of AHSV serotype 6.  
The specific 240 bp PCR products were amplified from all 
AHSV serotypes used in the study, and they were visualized on 
ethidium bromide-stained agarose gel. 
 The Amplification product was not detected when the RT-PCR 
assay was applied to RNA from bluetongue virus (BTV) or palyam 
virus.  
 This specific 240 bp PCR product was obtained from an mount of 10 
pg ,1.0 pg, 100fg, RNA from AHSV serotype (6). 
The results of this study showed that the described RT-PCR 
assay, using the mentioned primers, could be applied for detection of 
AHSV serotypes. 
 X
In conclusion, the AHSV RT- PCR can solve the problems 
which are found in virus isolation procedures. The rapidity, sensitivity 
and specificity of the RT- PCR assay would greatly facilitate detection 
of AHSV infection in an out break among susceptible equine. 
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  ﺔﺧﻼﺻﻪ اﻷﻃﺮوﺣ
 
ﻓﻴﺮوس ﻣﺮض  ) ﻓﻴﺮوس ﻃﺎﻋﻮن اﻟﺨﻴﻞ اﻻﻓﺮﻳﻘﻰأﺟﺮﻳﺖ هﺬة اﻟﺪراﺳﻪ ﻟﻜﺸﻒ ﻣﻮرﺛﺎت
  .ﺑﺎﺳﺘﺨﺪام ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ اﻟﻌﻜﺴﻰ  .وذﻟﻚ ،  اﻟﺨﻼﻳﺎ اﻟﻤﺴﺘﺰرﻋﺔ اﻟﻤﺼﺎﺑﺔﻓﻲ( اﻟﻨﺠﻤﺔ
 ﺧﻼﻳﺎ اﻟﺰرع  ﻓﻲ  واﺳﺘﺰراﻋﻪ أﺟﺮى اﻟﻜﺸﻒ ﻋﻠﻰ ﺗﺴﻌﺔ  اﻧﻤﺎط ﻣﺼﻠﻴﺔ ﻟﻠﻔﻴﺮوس ﺣﻴﺚ 
   .ﺎ اﺳﺘﺨﻼص اﻟﺤﻤﺾ اﻟﻨﻮوى اﻟﺮﻳﺒﻰ ﻣﻨﻬ. (ﻓﻴﺮو)اﻟﺨﻠﻮى 
 ﻣﻦ ﺟﻴﻨﻮم اﻟﻨﻤﻂ 3 رﻗﻢ هﺬة اﻟﺘﺠﺮﺑﺔ زوج ﻣﻦ اﻟﻤﺒﺎدﺋﺎت ﻣﺸﺘﻖ ﻣﻦ اﻟﻔﺺ ﻓﻲ اﺳﺘﺨﺪم  
د ﻗﻠﻴﻞ ﻣﻦ اﻟﺨﻼﻳﺎ اﻟﻤﺼﺎﺑﺔ واﻟﺬى ﻳﺘﻄﻠﺐ ﻋﺪ،   ﻟﻔﻴﺮوس ﻃﺎﻋﻮن اﻟﺨﻴﻞ اﻻﻓﺮﻳﻘﻰ6اﻟﻤﺼﻠﻰ 
 ﻓﻲ ى اﻟﺘﻰ اﺳﺘﺨﺪﻣﺖﺣﻤﺎض اﻟﻨﻮوﻳﺔ اﻻﺧﺮ اﻻﺎرﻧﺔ ﻣﻊ ﺑﻮادىء هﺠﻴﻦ ﻣﻮﺟﺒﺔ ﻣﻘإﺷﺎرة ﻟﻺﻧﺘﺎج
  .اﻟﻜﺸﻒ ﻋﻦ ﻓﻴﺮوس ﻃﺎﻋﻮن اﻟﺨﻴﻞ اﻻﻓﺮﻳﻘﻰ 
 زوج ﻗﺎﻋﺪى ﻣﻦ ﺟﻤﻴﻊ اﻻﻧﻤﺎط 042ﻧﺎﺗﺞ ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ اﻟﺒﺎﻟﻎ ﻃﻮﻟﻪ ﺗﻢ إآﺜﺎر 
وﺗﻢ إﻇﻬﺎرﻩ ﻓﻰ هﻼم ، ﻟﺪراﺳﺔ اﻟﻤﺼﻠﻴﺔ ﻟﻔﻴﺮوس ﻃﺎﻋﻮن اﻟﺨﻴﻞ اﻻﻓﺮﻳﻘﻰ اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻰ ا
  .  اﻟﻤﺼﺒﻮغ ﺑﺒﺮوﻣﻴﺪ اﻻﻳﺜﻴﺪﻳﻮم اﻻﻏﺎروز
 هﺬا اﻟﺰوج ﻣﻦ اﻟﺒﻮادىء ﺧﺼﻮﺻﻴﺔ ﻟﻬﺬة اﻟﻔﻴﺮوﺳﺎ ت ﺣﻴﺚ ﻟﻢ ﻳﺘﻢ إآﺜﺎر اﻟﻨﺎﺗﺞ ﻋﻨﺪ أﻇﻬﺮ
إﺟﺮاء ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ اﻟﻌﻜﺴﻰ ﻋﻠﻰ اﻟﺤﻤﺾ اﻟﻨﻮوى اﻟﺮﻳﺒﻰ اﻟﻤﺴﺘﺨﻠﺺ ﻣﻦ 
  . اﻟﻠﺴﺎن اﻻزرق أو ﻣﻦ ﻓﻴﺮوس ﺑﺎﻟﻴﺎم  ﻓﻴﺮوس ذاتﻓﻴﺮوﺳﺎت أﺧﺮى ﻣﻦ ﻧﻔﺲ اﻟﻌﺎﺋﻠﺔ   ﻣﺜﻞ
هﺬا اﻟﻨﺎﺗﺞ ﻓﺎﺋﻖ اﻟﺨﺼﻮﺻﻴﺔ ﺗﻢ إآﺜﺎرﻩ ﻣﻦ آﻤﻴﺎت ﻣﺨﺘﻠﻔﺔ ﻣﻦ اﻟﺤﻤﺾ اﻟﻨﻮوى اﻟﺮﻳﺒﻰ 
،   ﺑﻴﻜﻮﺟﺮام 01 ﻟﻔﻴﺮوس ﻃﺎﻋﻮن اﻟﺨﻴﻞ اﻻﻓﺮﻳﻘﻰ  وهﻰ 6اﻟﻤﺴﺘﺨﻠﺺ ﻣﻦ اﻟﻨﻤﻂ اﻟﻤﺼﻠﻰ 
ﻣﻦ ﺟﻴﻨﻮم اﻟﻔﻴﺮوس أى ﻣﺎ ﻳﻌﺎدل أو ﻳﻔﻮق ﺣﺴﺎﺳﻴﺔ ﻋﺰل .   ﻓﻤﺘﻮﺟﺮام001  ﺑﻴﻜﻮﺟﺮام و 0.1
ﺬا ﻣﺎ ﻳﺆآﺪ ﺣﺴﺎﺳﻴﺔ ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ اﻟﻌﻜﺴﻰ ﻓﻰ وه. اﻟﻔﻴﺮوس ﺑﺎﻟﻄﺮق اﻟﺘﻘﻠﻴﺪﻳﺔ
  .اﻟﻜﺸﻒ ﻋﻦ ﻓﻴﺮوس ﻃﺎﻋﻮن اﻟﺨﻴﻞ اﻻﻓﺮﻳﻘﻰ 
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ﻓﺎن ﻧﺘﺎﺋﺞ هﺬة اﻟﺪراﺳﺔ ﺗﻮﺿﺢ أن ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ اﻟﻌﻜﺴﻰ ﺑﺎﺳﺘﺨﺪام اﻟﺒﺎدﺋﺎت ،ﺧﺘﺎﻣﺎ 
ذو ﺧﺼﻮﺻﻴﺔ و ﺣﺴﺎﺳﻴﺔ ،ﺳﺮﻳﻊ ،ﻳﻤﻜﻦ إﺳﺘﺨﺪاﻣﺔ آﺎﺧﺘﺒﺎر ﺗﺸﺨﻴﺼﻰ ﺑﺴﻴﻂ ، اﻟﻤﺬآﻮرة ﺳﺎﺑﻘﺎ
ﺼﻌﻮﺑﺎت اﻟﻤﻮﺟﻮدة ﻓﻰ اﻟﻄﺮق اﻟﺘﻘﻠﻴﺪﻳﺔ  اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻰ ﺗﺸﺨﻴﺺ ﻓﻴﺮوس ﻃﺎﻋﻮن ﻟﺤﻞ اﻟ
  .اﻟﺨﻴﻞ اﻻﻓﺮﻳﻘﻰ 
ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ اﻟﻌﻜﺴﻰ ﻟﻠﻜﺸﻒ ﻋﻦ  اﺳﺘﺨﺪام  دراﺳﺎت ﻻﺣﻘﻪ،ﻓﻲ  ﻳﻤﻜﻦ  
 ﻣﺜﻞ اﻟﺪم وأﻧﺴﺠﺔ اﻟﺤﻴﻮاﻧﺎت ﻻﻓﺮﻳﻘﻰ ﻣﺒﺎﺷﺮة ﻓﻰ ﻋﻴﻨﺎت  اآﻠﻨﻴﻜﻴﻪ ﻓﻴﺮوس ﻃﺎﻋﻮن اﻟﺨﻴﻞ ا
  (2 وب1ب)ﻟﻠﺒﺎدﺋﺎت اﻟﺨﺎرﺟﻴﺔ  ( 4 وب3ب)ﺑﺎﺳﺘﺨﺪام ﺑﺎدﺋﺎت داﺧﻠﻴﺔ اﻟﻤﺼﺎﺑﺔ ﻃﺒﻴﻌﻴﺎ وذﻟﻚ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
CHAPTER ONE 
INTRODUCTION AND GENERAL LITERATURE REVIEW 
 
1. The virus: 
African horse sickness (AHS) (Peste equina africana, Peste equine) 
is an infectious, noncontagious arthopod-borne disease of equidae, caused 
by a double-stranded RNA orbivirus belonging to the family Reoviridae 
(Roy P.,et .,al 1991). The genus Orbivirus also includes bluetongue virus, 
epizootic hemorrhagic disease virus, and palyam virus which have similar 
morphological and biochemical properties with distinctive pathological 
and antigenic properties as well as host ranges. The genome of AHS virus 
(AHSV) is composed of ten double-stranded RNA segments, which 
encode seven structural proteins (VP1-7),) most of which have been 
completely sequenced for AHSV serotypes 4, 6 and 9 (Roy P.,et .,al 
1991), and four nonstructural proteins (NS1, NS2, NS3 and NS3A) 
(Grubman M. & Lewis S. 1992). Proteins VP2 and VP5 form the outer 
capsid of the virion, and proteins VP3 and VP7 are the major inner capsid 
proteins. Proteins VP1, VP4 and VP6 constitute minor inner capsid 
proteins. Recently it was indicated that NS3 proteins are the second most 
variable AHSV proteins (Van Niekert et al., 2001). The most variable 
being the major outer capsid protein, VP2. This protein, VP2, is also the 
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principal protein responsible for distinguishing AHSV serotypes and, 
together with VP5 are respensible for virus neutralisation activity 
(Martinez-Torrecuadrada et al., 1999). Nine antigenically distinct 
serotypes of AHSV have been identified by virus neutralisation, but no 
cross-reactions with other known orbiviruses have been,reported. 
2. Etiology: 
The etiological agent of AHS is a typical orbivirus measuring 68-
70 nm in diameter, and the virion is composed of a double-layered 
protein shell.  
The virus is present in the blood and certain organs such as spleen, 
lung, and lymph nodes in reasonably high concentration, whereas only 
traces are found in serum, tissue fluids, excretions, and secretions 
(Erasmus, B.J.1972). Viremia generally lasts for about 4-8 days and 
roughly parallels the febrile reaction. In exceptional cases, viremia may 
last as long as 17 days in the horse and 28 days in zebra and donkeys.  
            The AHS virus is relatively heat stable, particularly in the 
presence of protein. It can be stored for at least 6 months at 4° C in saline 
containing 10 percent serum. Blood in OCG preservative (500 ml 
glycerin, 500 ml distilled water, 5 g sodium oxalate, and 5 g carbolic 
acid) can remain infective for more than 20 years; lyophilization may 
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preserve infectivity for as long as 40 years. The virus is readily 
inactivated at pH values lower than 6.3, but it is relatively stable between 
values ranging from 6.5 to 8.5.  
Nine distinct serotypes of AHSV are known, the last of which was 
isolated in 1960. This suggests that, despite its segmented genome, the 
virus can be regarded as genetically stable and those new serotypes do not 
readily develop. The present nine serotypes probably evolved over many 
centuries.  
3. Host Range:                
Horses, mules, and donkeys have historically been known as hosts 
for AHS virus, as reflected in the name of the disease. In view of the high 
mortality rate suffered by horses and mules, these species should be 
regarded as accidental or indicator hosts. That AHS failed to establish 
itself outside tropical regions of Africa tends to indicate that neither 
horses nor mules or donkeys remain long-term carriers of AHS virus and 
are therefore not essential for the permanent persistence of the infection 
in a particular region. Zebra may fulfill this role, but no irrevocable proof 
has been found to substantiate this view.  
The dog has long been known to be susceptible to experimental 
infection (Theiler, A.1906) Infection of dogs also readily occurs 
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following ingestion of infected horse meat (Bevan, L.E.W.1911). 
However, it is extremely unlikely that this species becomes infected by 
insect bites, and it is generally accepted that dogs play no role in the 
spread or maintenance of AHS (Mcintosh B.M. 1955).  
Camels can ostensibly become apparently infected with AHS virus, but 
few details are available as to the level and duration of viremia in this 
species and its role, if any, in the epizootiology of the disease. A high 
percentage of African elephant serum samples reacted positively against 
AHS virus in complement fixation tests (Davies, F.G., and Otieno, S. 
1977), but no neutralizing antibodies could be demonstrated in such 
samples. No evidence of virus replication could be found in elephants 
artificially infected with AHS virus (Erasmus et. al, 1976). It can 
therefore be concluded that the African elephant is not susceptible to 
infection and that the putative serological evidence resulted from 
abnormal reactions of elephant sera in a complement fixation test. 
 There is no evidence that man can become infected with field strains of 
AHS virus, either through contact with infected animals or from working 
in laboratories. However, it has been shown that certain neurotropic 
vaccine strains may cause encephalitis and retinitis in humans following 
transnasal infection (Swanepoe et. al 1992.).   
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4. Geographic Distribution: 
African horse sickness appears to be endemic in tropical regions of 
central Africa from where it regularly spreads southwards to southern 
Africa. The Sahara Desert forms a formidable barrier against northward 
spread. Occasionally the infection does reach northern African countries, 
either by spread along the Nile valley or along the West Coast of Africa. 
The disease has also occurred outside Africa on a few occasions, the most 
notable of which was the major outbreak in the Near and Middle East 
from 1959 through 63 and in Spain (1966 and 1987-1990) (Lubroth, J. 
1988).   
In temperate regions such as South Africa, AHS has a definite 
seasonal occurrence. The first cases are usually noticed towards 
midsummer, and the disease disappears abruptly after the onset of cold 
weather in autumn. The disease is most prevalent in warm, low-lying 
moist areas such as valleys and marshes.  
5. Transmission: 
African horse sickness is a non contagious disease, and the virus 
was the first shown to be transmitted by midges (Culicoides spp.) (Dutoit, 
R. M.,1944). The most significant vector seems to be Culicoides imicola, 
but other species, such as C. variipennis, which is common in many parts 
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of the United States, should also be considered as potential vectors 
(Boorman et al.1975).  
Although other insects such as mosquitoes have been implicated as 
biological vectors, and large biting flies (e.g., Stomoxys, Tabanus) may 
transmit AHS virus mechanically, the role of these insects in the 
epizootiology of the disease is regarded as absolutely minimal compared 
with that played by the Culicoides species  
The virus is transmitted biologically by midges, and these insects 
are most active just after sunset and at about sunrise.  
        Generally, midges disperse only a few kilometers from their 
breeding sites, but it has been postulated that they can be borne for longer 
distances on air currents (Sellers et al., 1977). Analysis of field 
observations on the progression of outbreaks indicates that wind-borne 
spread of midges may assist the short-distance spread of the disease but 
that long-distance jumps of the infection are invariably the result of 
movement of infected Equidae.  
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6. Diagnosis: 
 6.1. Clinical signs:                                                                    
             There are four classical forms of AHS:  
1. The peracute or Pulmonary form 
2. The subacute edematous or Cardiac form 
3. The acute or mixed form  
 4. Horse sickness fever (Erasmus B.J., 1973).                                                   
6. 1. 1. The peracute or pulmonary form: 
             This has a short incubation period (3–5 days), is characterized by 
very marked severe dyspnoea and progressive respiratory involvement. 
An acute febrile reaction, lasting 1–2 days and reaching a maximum of 
approximately 40–41°C, may be the only sign. This is followed by 
various degrees of respiratory distress – respiratory rate may increase to 
60 or even 75 breaths/minute. The animal may be observed to stand with 
its forelegs spread apart, its head extended and its nostrils fully dilated.                               
                Common and spasmodic coughing may be observed terminally, 
with frothy fluid exuding from the nostrils. Death usually occurs within a 
few hours after the first clinical signs are observed, the animal having 
literally drowned in its own serous fluid. The pulmonary form is usually 
observed in completely susceptible animals, animals infected with a 
highly virulent strain of virus, or animals that are worked during the 
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febrile stage of the disease. Recovery from this form is very rare, 
occurring in <5% of cases. 
 
6.1.2. The sub acute form: 
                 The incubation period of the sub acute, edematous or cardiac 
form varies from about 7 to 14 days, and the onset of clinical disease is 
marked by a febrile reaction (39–41°C) that lasts for 3–6 days. Shortly 
before the decline of the fever, characteristic edematous swellings may 
appear. These initially involve the temporal or supraorbital fossae and the 
eyelids, and later extend to the lips, cheeks, tongue, intermandibular 
space and laryngeal region. Subcutaneous edema sometimes extends a 
variable distance down the neck towards the chest and, in severe cases, 
may involve the chest and shoulders, but generally not the lower limbs. 
Terminally, petechial hemorrhages may be observed in the conjunctivae 
and under the ventral surface of the tongue. The animal finally becomes 
restless and may show signs of colic before death from cardiac failure. 
Difficulty in swallowing due to paralysis of the esophagus is also seen. 
The mortality rate is about 50% and death usually occurs within 4–8 days 
after the onset of the febrile reaction. In recovering cases, swelling 
gradually subsides within a period of 3–8 days. This clinical form of AHS 
is usually associated with infection by virus strains of low virulence or is 
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encountered in immune animals infected by heterologous virus strains, or 
may be a function of biological variation in the infected animal. 
6.1.3The acute or mixed form: 
     This form represents a mixture of the pulmonary and cardiac forms. 
Although seldom diagnosed clinically, it is the most common form, and it 
seen at post-mortem examination in most fatal cases of AHS in horses 
andmules. 
 
6.1.4. The febrile form: 
          Horse sickness fever is the mildest form and is frequently 
overlooked in natural outbreaks. The incubation period varies from 5 to 
14 days, and is followed by a febrile reaction (39–40°C) of the remittent 
type, with morning remissions and afternoon exacerbations, lasting for 5–
8 days. Apart from the febrile reaction, other clinical signs are rare. 
7. Gross Lesions: 
          The lesions observed at necropsy examination depend largely on 
the clinical form of disease manifested by the animal before death (. 
Erasmus, B.J. 1972). In the peracute form the most characteristic changes 
are edema of the lungs or hydrothorax. In very per acute cases, extensive 
alveolar edema and mottled hyperemia of the lungs are seen, whereas in 
cases with a somewhat more protracted course extensive interstitial and 
sub pleural edema is also present, but hyperemia is less evident. 
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Occasionally the lungs may appear reasonably normal, but the thoracic 
cavity may contain as much as 8 L of fluid. Other less commonly 
observed lesions are per aortic and per tracheal edematous infiltration, 
diffuse or patchy hyperemia of the glandular fundus of the stomach, 
hyperemia and petechial hemorrhages in the mucosa and serosa of the 
small and large intestines, sub capsular hemorrhages in the spleen, and 
congestion of the renal cortex. Most of the lymph nodes are enlarged and 
edematous, especially those in the thoracic and abdominal cavities. 
Cardiac lesions are usually not conspicuous, but epicardial and 
endocardial petechial hemorrhages are sometimes evident.  
In the cardiac form the prominent lesion is a yellow gelatinous 
infiltration in the subcutaneous and intramuscular fascia primarily of the 
head, neck, and shoulders. Occasionally the lesion may also involve the 
brisket, ventral abdomen and rump. Hydropericardium is a common 
feature, and there are extensive petechial and ecchymotic hemorrhages on 
the epicardium and endocardium, particularly of the left ventricle. The 
lungs are usually normal or only slightly engorged, and the thoracic 
cavity rarely contains excess fluid. The lesions in the gastrointestinal tract 
are generally similar to those found in the pulmonary form, except that 
sub mucosal edema of the cecum, large colon, and rectum tends to be far 
more pronounced.  
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In the mixed form the lesions seem to represent a combination of 
those found in the pulmonary and cardiac forms.  
8. Morbidity and Mortality 
              In susceptible horse populations, the fatalities range between 70 
and 95 percent, and the prognosis is extremely poor. In mules, the 
mortality rate is about 50 percent and in the European and Asian donkey 
about 5-10 percent. No mortality is observed among African donkeys and 
zebra.  
In enzootic regions, the mortality rate is modified in proportion to 
the immunity acquired by the equine population as a result of previous 
vaccination or exposure to natural infection. (Erasmus B.J., 1973).                                      
9. Laboratory Diagnosis:    
9.1. Virus isolation: 
9.1.1. Samples for virus isolation: 
Heparinised blood samples taken in acute phase from sick animals 
,and organs such as spleen ,lungs, lymph nodes and heart from a dead 
animals were suitable for virus isolation (Blackburn and 
Swanepoel,1988a). 
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9.1.2. Tissue culture: 
Cultivation of AHSV in sheet of Monkey stable (MS), baby 
hamster kidney (BHK-21) and African green monkey kidney (Vero) cell 
lines were, all used for virus isolation. (Hazrati and Ozawa, 1965)   
The virus showed cytopathic effect in 2-3 days, when both virulent 
and attenuated neurotropic strains of AHSV were inoculated in monkey 
kidney stable (MS) cell line. Following the virus inoculation, the 
incubation period become shorter. There was an eight hours latent period 
before the virus production was demonstrated. After 10 days from 
inoculation, plaques are formed, their diameters ranged in size from 1-3 
mm (Ozawa and Hazrati, 1964). The cytopathic effect (CPE) appeared in 
the cell cultures 2-5 days after inoculation, in form of cell rounding and 
detaching from the surface. Three serial passages were completed on any 
simple specimen before the isolation attempt was considered negative 
(Carol House, 1992). 
9.1.3. Chicken embryos  
Inoculation of fertile eggs in yolk sac, is also possible for 
propagation of neurotropic and viscerotropic AHSV strains.  In the first 
passage the embryos mortality was low and it's increased to 100% by the 
sixth passage (Goldsmith, 1967). 
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9.1.4. Newborn Mice: 
AHS virus isolation can be done by intracerebral inoculation into 
suckling mice (1-3 day – old-BALB/C, CD-1Swiss). After 2-3 days mice 
developed nervous signs if the specimen is positive. The brains of the 
mice are collected and homogenized as suspension to make two or three 
more passages by reinculation intercerebrally into new born mice before 
the specimen is considered to be positive.  (Alexander, 1935b). 
9.2. Serological tests: 
9.2.1. Agar Gel Precipitation test (AGPT)  
           The success of AGPT in the diagnosis of AHS viral infection was 
established by Hug and An sari (1961). 
           The AGPT was described as group specific test for AHS when the 
virus was isolated in suckling mice, (Hajer et al., 1980). When AHSV 
antigen and positive serum diffused towards each other through an agar 
medium, two precipitin lines were found (Ozawa et al., 1968).The agar 
gel immunodiffusion (AGID) test, currently used as standard serological 
test, is complicated by cross-reactions between related orbiviruses 
(Aradaib et al., 1995) 
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9.2.2. Serum Neutralization Test (SNT): 
            Serum neutralization test using the tube technique was established 
in (1966) by Hazarati and Ozawa.They used this technique in the 
diagnosis of AHS virus using cell culture (MS) as host system.  
            The serum neutralization test were also carried out to detect 
antibodies in sera of equidae using vero cell culture in 96 well flat tissue 
culture microtitre plates (Binepal et al., 1992) . The test can also be used 
for serotyping the virus in tissue culture (Hazrati &Ozawa, 1965b, 
Blackburn &Swanepoel, 1988b). 
9.2.3 Fluorescent Antibody Technique (FAT):  
          Direct and indirect flurescent antibody techniques were 
successfully applied to the identification of virus of AHS isolates in tissue 
culture and for the screening of sera for antibody detection . The test was 
proved to be group specific test. (Davies &Lund, 1974 )  
9.2.4. Haemagglutination test (HA):   
           Tokuhisa et al., (1982) proved that erythrocytes from horse, sheep, 
cattle, goat, rabbits, guinea pig and poultry were agglutinated by 
concentrated culture fluid of AHSV at 4C°, room temperature and 37C°. 
Optimal titers were obtained when the virus was diluted in normal saline 
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of PH ranging between 6.0 and 7.5. HA test was also used as a specific 
test for diagnosis of AHSV. (Tewari et al., 1972). 
9.2.5. Passive Haemagglutination (PHA)  
           (Soliman &Salama ,1979 ) Passive haemagglutination test for 
detection of AHS antibodies was carrier out by using partially purified 
AHS virus soluble antigen, it gave a positive reaction with tanned 
sensitized horse RBCs . 
9.2.6. Immunoblotting:  
            For the determination of anti- AHSV antibodies, antibodies to 
viral proteins which separated by electrophoresis and transferred to 
nitrocellulose paper, were useful.  Small numbers of sera is especially 
suitable for this test (OIE, 2000). 
             Immunoblotting procedure had been developed for the detection 
of (AHSV) and identification of antibodies specific for viral proteins 
(VP) and non-structural proteins (NS) (Bougrine et al., 1998). 
9.2.7. Enzyme Linked Immunosorbent Assay (ELISA): 
          ELISA was proved to have a great potential as quantitative 
serological tool in the detection of antibodies for several viral infection 
(Williams 1987).  The sensitivity and specificity of ELISA are superior to 
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the complement fixation test (CFT), which is commonly used as routine 
quantitative serological test for AHSV diagnosis. 
          Indirect sandwich ELISA was used for detection of AHSV by 
Plessis et al. (1990).  Asero group specific, indirect sandwich ELISA was 
developed for rapid detection of AHSV (Hamblin et al., 1991). 
The problems associated with the use of the (AGID) test have been 
solved by using monoclonal antibodies (MAbs) in competitive ELISA 
(cELISA) technique (Laviada et al., 1992) .  To confirm the orbivirus 
identity, agroup –specific sandwich ELISA (S –ELISA) was also 
developed recently (Crafford et al., 2003). 
9.2.8. Complement fixation test: 
          Macintosh (1958) reported that complement fixation test (CFT) 
with Guinea pig RBCs and acetone ether extracted mouse brain antigen 
was a group specific test and was suitable for the detection of all the 
established antigenic types. 
          CFT can be used for typing the AHSV, there were no serological 
cross reactions between AHSV and other orbivirus ,(Ozawa &Bahrami 
1968) .For demonstration of group –specific antibodies against AHSV, 
CFT is frequently used , a sucrose –acetone .mouse brain extract is 
commonly used as antigen (Paweska et al., 2000) . 
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9.3 Molecualr Diagnosis 
9.3.1 Nucleic acid hybridization: 
     Serogroup-specific and serotype-specific complementary DNA 
(cDNA) probes derived from different AHSV genome segment have been 
developed to address virus isolation problems (Zientara et al., 1998). 
However, the minimum amount of AHSV RNA these cDNA probes 
could detect was found to be in the nanogram range with dot-blot 
hybridization (Zientara et al., 1998).   
9.3.2. Polymerase chain reaction (PCR): 
       The polymerase chain reaction (PCR) is a molecular biological 
technique (Smithsonian Institution, 2006) for isolating and exponentially 
amplifying a fragment of DNA, via enzymatic replication, without using 
a living organism. As PCR is an in vitro technique, it can be performed 
without restrictions on the form of DNA, and it can be extensively 
modified to perform a wide array of genetic manipulations. 
   Invented in 1983 by Kary Mullis, PCR is now a common technique 
used in medical and biological research labs for a variety of tasks, such as 
the sequencing of genes and the diagnosis of hereditary diseases, the 
identification of genetic fingerprints (used in forensics and paternity 
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testing), the detection and diagnosis of infectious diseases, and the 
creation of transgenic organisms.  
     PCR is used to amplify specific regions of a DNA strand. This can be 
a single gene, just part of a gene, or a non-coding sequence. Most PCR 
methods typically amplify DNA fragments of up to 10 kilo base pairs 
(kb), although some techniques allow for amplification of fragments up to 
40 kb in size. (Cheng S, et.,al 1994).  
PCR, as currently practiced, requires several basic components (Joseph 
Sambrook et.,al 2001). These components are: 
• DNA template that contains the region of the DNA fragment to be 
amplified  
• One or more primers, which are complementary to the DNA 
regions at the 5' and 3' ends of the DNA region that is to be 
amplified.  
• a DNA polymerase (e.g. Taq polymerase or another DNA 
polymerase with a temperature optimum at around 70°C), used to 
synthesize a DNA copy of the region to be amplified  
• Deoxynucleotide triphosphates, (dNTPs) from which the DNA 
polymerase builds the new DNA  
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• Buffer solution, which provides a suitable chemical environment 
for optimum activity and stability of the DNA polymerase  
• Divalent cation, magnesium or manganese ions; generally Mg2+ is 
used, but Mn2+ can be utilized for PCR-mediated DNA 
mutagenesis, as higher Mn2+ concentration increases the error rate 
during DNA synthesis ( Pavlov AR, et.,al 2004)  
• Monovalent cation potassium ions  
The PCR is carried out in small reaction tubes (0.2-0.5 ml volumes), 
containing a reaction volume typically of 15-100 µl, that are inserted into 
a thermal cycler. This is a machine that heats and cools the reaction tubes 
within it to the precise temperature required for each step of the reaction. 
Most thermal cyclers have heated lids to prevent condensation on the 
inside of the reaction tube caps. Alternatively, a layer of oil may be 
placed on the reaction mixture to prevent evaporation. 
9.3.3 Reverse transcriptase polymerase chain reaction (RT-PCR): 
Reverse transcriptase polymerase chain reaction (RT-PCR) is based on 
the polymerase chain reaction (PCR). More importantly it is based on the 
process of reverse transcription, which reversely transcribes RNA into 
cDNA. RT initially isolated from retroviruses.  
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       The techniques of RT-PCR allows the formation of cDNA 
(complementary or copy DNA) from RNA, which stores the sequence of 
RNA (such as messenger RNA, mRNA) in the more stable form of 
nucleic acid, DNA. This reverse transcription from RNA into its reverse 
complement DNA (cDNA) is the first step of a usually two-step process 
of RT-PCR. Furthermore, by copying the RNA into cDNA, it will be 
possible to amplify the cDNA sequence by using primers specific for the 
DNA sequence. This amplification is the final second major step of the 
two-step process of RT-PCR. 
9.3.4. The Process of RT-PCR: 
The First step of RT-PCR is referred to as the "first strand reaction". In 
the first-strand reaction, complementary DNA also termed cDNA, is 
made from the messenger RNA template of interest using oligo dT 
(oligonucleotide poly-dTs act similar to primers and bind to the 3' polyA 
sequence located at the 3' UTR - untranslated region, which are present in 
most mRNAs), dNTPs, and an RNA-dependent DNA polymerase 
(reverse transcriptase) through the process of reverse transcription.  
These factors are combined in a reverse transcriptase buffer for 1 hour at 
37°C. After reverse transcriptase reaction is complete, and the cDNA has 
been synthesized, RNaseH is added (an RNA digestion enzyme) which 
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digests the RNA away from the RNA-cDNA hybrid. After incubation 
with RNaseH, standard PCR or polymerase chain reaction is conducted 
using DNA oligo primers specific for the sequence of interest. This 
second step is referred to as the "second strand reaction". 
Thus by adding the thermostable taq DNA polymerase, upstream and 
downstream DNA primers, the single stranded DNA becomes double 
stranded and is amplified, allowing the detection of even rare or low copy 
mRNA sequences by amplifying its complementary DNA (PCR station, 
2006). 
10. Differential Diagnosis: 
           Erasmus (2003) reported the clinical signs of AHS particularly 
when not fully developed, to be confused with other infections notably 
Equine Encephalosis and Equine Viral Arthritis (EVA). Under the same 
epizootiological conditions as AHS, those diseases occur. Usually horses  
suffering from Equine Encephalitis do not have characteristic lung edema 
or subcutaneous edema, and the mortality rate are considerably lower 
than in AHS. Sever cases of EVA may readily be confused with AHS , 
the present of ventral edema in EVA of lower limbs ,and much lower 
mortality rate should allow differentiation .  
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           The early stage of piroplasmosis disease before blood parasites 
demonstrated and anemia develops, may be confused with AHS,   also 
trypanosomasis shares this sign with the disease .(OIE ,2002). 
            Erasmus (2003), found the necropsy lesions of AHS can be 
confused with those of Purpura Hemorrhagica ,in which the hemorrhages 
and edema seem to be more sever and widely spread than in AHS and 
usually involve the limbs and lower abdomen .  
            Hemorrhages and sudden death in Anthrax can be confused with 
AHS. (OIE, 2002).   
11. Control: 
11.1. Preventive measures: 
            Several preventive measures should be taken, when the disease is 
introduced into a country, to prevent further spread and eventually to 
eradicate the virus in the shortest possible time .Equid animals imported 
from infected countries should be quarantined in insect-proof facilities at 
the point of entry. (Erasmus, 2003) 
             Affected equidae should be eliminated immediately and non-
infected one vaccinated and rested for 2 weeks and should be kept in 
insect-proof housing because vaccine failure may occur .Vector control 
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should also be adopted by using insecticides repellent .Aircrafts flying 
from endemic areas to countries free of the disease should be sprayed 
with insecticides on arrival. 
            An international plan to prevent the spread of AHS involved the 
establishment of immune buffer zones around infected areas; extensive 
production of vaccines and internationally coordinated vaccination 
campaigns was developed. (Losos, 1986). 
 11.2. Vaccines:   
11.2.1. Live vaccines: 
            In India adverse reactions to the polyvalent AHS mouse adapted 
vaccine   occurred. (Parvi & Anderson.1963).  
            Losos, (1986) showed that ,the adaptation of the virus to the brain 
of adult mice resulted in neurotropic vaccine that occasionally caused 
encephalitis in horses ,mules and particularly in donkeys .The mouse 
brain polyvalent vaccine was produced by using up to eight strains of 
neurotropic virus propagated intracerebrally in mice . After 5 to 13 days a 
mild fever appeared in vaccinated horse .The vaccine provides protection 
in 21 days. After 6 months the full immunity is reached and lasts for up to 
5-8 years. Foals from immune mothers are effectively vaccinated only 
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after 7month of age. Strains attenuated in mice are potentially neurotropic 
for horse. 
            Blackburn and Swanepoel, (1988a) said that, immunization with 
polyvalent attenuated vaccines of AHSV ,leads to broader response to 
various serotypes and to higher titre, but some horses failed to respond to 
one more serotypes . 
            Monovalent mouse brain and tissue culture vaccine of AHSV 
serotype (9) which contained approximately 6.6 log 10TCID 50 per dose 
was prepared and evaluted. No adverse effect due to vaccination was 
observed and vaccines were safe in horse, mules and donkeys .The 
vaccine titer decreased (0.5 log 10 TCID 50), when it was kept at 37C° 
for 7 days. (Hazarti & Ozawa 1965b).  
          A polyvalent attenuated tissue culture AHS vaccine consisted of 7 
neurotropic viruses was prepared, and was used in the Middle East. It 
elicited a satisfactory immune response in vaccinated horses. (Mirchamsy 
& Taslimi, 1964). 
11.2.2. Inactivated vaccines: 
            The virus was inactivated with either B-propilactone at 0.2 
percent, or with formaldehyde in concentration of 1:8000. In order to 
enhance the immunogenicity, an aluminum hydroxide was added to the 
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vaccine as an adjuvant .Neutralizing antibodies developed within 4 
weeks, when a single dose of either vaccine was used. Much higher 
neutralizing antibodies were present in sera 6 month later. When two 
injections of inactivated vaccine were administered at interval of 4 weeks. 
            The animals were resistant to a challenge dose of virulent virus. 
(Mirchamsy & Taslimi, 1967). 
11.2.3. Natural Immunity: 
            Alexander ,(1936) ,found that recovery from infection lead to the 
development of complement fixing ,neutralizing and haemagglutination 
inhibiting antibodies. Complement fixing antibodies are detectable in the 
circulation as early as five days after infection. The formation of 
neutralizing antibodies however, is somewhat slower and although they 
may be detected as early as five days after the cessation of the febrile 
reaction, they reach a peak much later and persist for an undetermined 
period at lower titers. 
            Generally  the level of antibody in sera of dams correlated with 
the level of antibody acquired from colostrums by their foals, and the rate 
of decline was proportional to the initial titre. Early immunization was 
recommended so as to control the losses of foals because maternal 
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antibody titre decline in 2-4 months after birth (Blackburn 
&Swanepoel,1988b) .  
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CHAPTER TOW 
MATERIALS AND METHODS 
2.1. Virus and cells: 
       The nine prototype vaccine strains of AHSV were obtained from 
(Institut Pasteur Dakar, Senegal). The viruses were processed as 
described previously (Aradaib et al., 1995). The virus vaccine strains 
were propagated on confluent monolayers of Vero cells (Figure 2.1). 
Vero cells were sub cultured in 25 ml Falcon tissue culture flasks. 
Glasgow minimal essential medium (GIBCO)                          
was used for growth and maintenance of cells.  All viruses were adapted 
to this cell line by 2-3 successive passages. The infectious materials were 
harvested when 80 % cytopathic effect (CPE) was observed (Usually 3-5 
days after infection) (Figure 2.2), and centrifuged at 1500Xg for 30 min 
and the cell-free supernatant was used for RNA extraction using QIAmp 
extraction kit (QIAmp, Hamburg, Germany)  
           
2.2. Extraction of viral nucleic acid from infected    
Cell culture and clinical sample: 
             AHSV dsRNAs were extracted from the infected cell culture 
supernatant fluid and from infected tissues using QIAmp viral RNA kit as 
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per manufacturers instructions. Briefly, 140 ul of virus suspention were 
added  to 560 ul AVL buffer containing carrier RNA into a 1.5 ml 
microcentrifuge tube and mixed by pulse-vortexing for 15 sec. The 
mixture was incubated at room temperature for 10 min. An amount of 
560 ul of absolute ethanol was added and mixed by pulse-vortexing for 
15 sec .An amount of 630 ul of the mixture were transferred to QIAmp 
spin column mounted on 2ml collection tube and centrifuged at 8000 rpm 
for min .The column was then transferred to another collection tube and 
the remaining 630ul of the mixture was again spined at the same speed. 
The column was then washed twice by 500 ul of washing buffers WB1 
and WB2, respectivly . finally , dsRNAs  were  carefully eluted by 60ul 
of buffer AVE equilibrated to room temperature .Total nucleic acid was 
quantified using aspectrophotometer at 260nm wavelength .                                  
 
2.3. Design of primers: 
            Primers were selected from the published  sequence of genome 
segment 3 of AHSV serotype 6 and used in these PCR assays (Williams 
et al .,1998) .Primers 1 and 2(P1 and P2) were selected for the synthesis 
of specific AHSV RT –PCR product . P1 included bases 281 -300 bp of 
the positive –sense strand of the genome segment 3: 5'-GAT AAA CGC 
GCC ACC GAA TT-3'. .P2 included bases 501 -520 bp of the 
complementary strand: 5'-TCT GGA TCA GCA ATC TCT GC-3'. AHSV 
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RT-PCR using primer P1 and P2 would result in a product of 240 base 
pair (bp). All primers were synthesized on a DNA synthesizer and 
purified using oligo-pak oligonucleotide purification columns as per 
manufacturer's instructions (Milligen/Biosearch, Millipore, Burlington, 
MA, USA ) .  
 
2.4. RT-Polymerase Chain Reaction (RT-PCR):  
            Amplification of the target sequence was preformed by using 
double reaction RT-PCR. 1.0 µl methyl mercuric hydroxide of 80 mM 
concentration was used to denaturent a mixture of 5 µl of the target RNA 
and 2 µl of primer .The primers were used at a concentration of 20µġ/µl. 
The mixture was incubated at 25°c for 10 min. To neutralize the mixture 
by, 1.0 µl of βeta mercapto ethanol, 1.0 µl of RNAase inhibitor, 8.0 µl of 
dNTPs (  2.0µl  of each dNTTP,dNATP,dNCTP,dNGTP ) . 
 Reverse transcription step used to synthesize complementary DNA from 
RNA template by  reverse transcriptase mixture which contained 2.7 µl of 
10ҳ PCR buffer , 5.0 µl of Mgcl2 of 1.5 mM concentration and 1.1 µl of 
the enzyme reverse transcriptase , . 8.8 µl of reverse transcriptase mixture 
was added to each PCR tube which was placed in the thermal cycler at 
42ºc for 30 minutes.  
          Amplification mixture composed 7.3 µl of 10ҳPCR buffer, 8.o µl 
of Mgcl2, 57 µl of ddH2o, and 1.0 µl Tag DNA polymerase at 
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concentration of 5units\µl. 73.3µl of the mixture added to each PCR tubes 
.     
            The RT-PCR was performed in TECHNE, (TC-412, USA) 
thermal cycler (Figure 2.3). Initial reverse transcription step was done at 
94ºc for 2 minutes followed by 30 cycles of amplification .Each cycle 
include denaturation at 94ºc for1 minute, annealing at 57ºc for 30 seconds 
and extension at 72ºc for 45 seconds .Final extention at 72ºc for 5 
minutes .  
2.5. Agarose gel electrophoresis:  
            The amplified products of cDNA transcribted from viral RNA 
molecules by RT-PCR were analyzed in agarose gel. The agarose gel 
preparation, running buffer preparation and electrophresis were carrid out 
as follows: 
   a) Preparation of 1 percent  Aagarose gel: 
One gram of agarose powder (molecular biology grade) was suspended in 
100 ml of Tris-boric acid-EDTA (TBE) burffer. The suspension was 
heated in microwave oven for few minutes until the agarose was 
completely melted .When cooled down 30-40 ml of melted agarose was 
poured in the gel try loaded with a comb. 
   b)Preparation of Tris-boric acid-EDTA: 
           107.81 gm    0.89 M Tris-(hydroxymethyl)-aminomethane . 
            55.03 gm     0.89 M Boric acid  
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            7.44 gm      0.20 M EDTA 2H2O. 
              Up to 1 litre distilled water. 
            This mixture (10× TBE) was dissolved on magnetic stirrer then 
another litre of distilled water was added tomprepare 5×buffer 
concentration. The buffer was then kept at room temperature and used at 
1× concentration for gel preparation and electrophoresis. 
        c) The molecular weight marker: 
            In each electrophoresis run, two microliters of a one hundred 
base-pair ladder molecular weight marker (MW marker ) was placed in 
the first lane. 
        d) Electophoresis: 
            The agarose gel was submerged in the buffer basin of the 
electrophoresis apparatus (Figure 2.4) filled with 1×TBE containing 
0.001% Ethidium bromide(50mg/ml). RT-PCR products with the MW 
marker were lodded in the gel after being stained with an indicator dye 
(Bromophenol blue). Constant electric current of 88 mV was then 
switched on for about 45 minutes to allow the migration of the amplified 
PCR products. The standard molecular weight marker (1Kb) was 
incorporated in each reaction for determination of the size of the 
amplified product by comparing this size with the separate 
distinguishable bands of the MW marker which were seen when the gel 
was stained with ethidium bromide. 
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The gel was then visualized under UV light using gel documentation 
apparatus (Figure 2.5).  Separate distinguishable bands were seen when 
the gel was stained with ethidium bromide .   
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Figure 2.1: Confluent monolayer of vero cells 
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Figure 2.2: 80% cytopathic effect (CPE) 
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Figure 2.3: Thermal cycler (TECHNE, TC-412, USA)  
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Figure 2.4: Electrophoresis apparatus 
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Figure 2.5: Gel documentation apparatus 
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CHAPTER THREE  
RESULTS  
  
3.1. Detection of AHSV vaccine strains:            
    
    The RT-PCR-based assay described offered sensitive and specific 
detection of all the nine AHSV vaccine strains used in this study. 
The specific 240 bp PCR products was visualized on ethidium bromide-
stained agarose gel from 1pg RNAof AHSV vaccine strains  (Figure 3.1). 
 
3.2 Specificity of AHSV RT-PCR : 
 
 The specificity studies indicated that the specific 240 bp PCR product 
was not detected from1ng RNA of bluetongue virus (BTV) and 1ng RNA 
of                                                                   Palyam virus (Figure 3.2). 
 
3.3 Sensetivity of AHSV RT-PCR : 
 
The sensitivity studies indicated that the specific 240 bp PCR product 
was obtained from an amount of 10pg ,1.0pg ,100fg ,RNA from AHSV 
serotype(6) (Figure 3.3). 
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Figure3.1: Detection of all the nine AHSV vaccine strains in 
infected cell culture. Visualization of the 240 bp specific AHSV 
PCR product on ethidium bromide-stained agarose gel from 1.0 pg 
RNA of nine different AHSV vaccine strains. Lane MW: 
molecular weight marker; Lanes 1-9: AHSV serotypes 1-9 of the 
vaccine strains. 
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Figure 3.2: Specificity of the Polymerase Chain Reaction for AHSV 
RNA. Amplification product was not detected from 1 ng of BTV RNA 
and Palyam virus. Lane MW: molecular weight marker; lane 1: 1 pg 
AHSV; lane 2: BTV and lane 3: Palyam virus. 
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Figure 3.3: Sensitivity of the Polymerase Chain Reaction for detection of 
AHSV. Visualization of the 240 bp specific-AHSV PCR product on 
ethedium bromide-stained agarose gel from 100 fg AHSV RNA. Lane 
MW: molecular weight marker; lanes 1-6: (AHSV-6) 10 pg, 1.0 pg, 100 
fg, 10 fg, 1.0 fg and 0.1 fg, respectively. 
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CHAPTER FOUR 
DISCUSSION 
    
Several serological methods to characterize AHSV such as serum 
neutralization, haemagglutination inhibition, complement fixation, and 
agar diffusion were used.Among these methods the neutralization test 
was most type specific and thus as as  most common used to determine 
antibody level as well as  serotyping (Hazrati et .al, 1965 b). 
          Aradaib et al., 1995 stated that serology is useful in 
epidemiological studies to identify previous infection with AHSV. The 
agar gel immunodiffusion (AGID) test which was used as a standard 
serological test, but there were some draw- backs such as the  cross-
reaction between related orbiviruses. 
 Monoclonal antibodies (MAbs) in competitive ELISA (cELISA) 
technique were used to solve the problems  associated with the use of the 
AGID test (Laviada et .al, 1992), but this technique is suitable only to 
blood and it takes at least 14 days for the production of anti-AHSV 
antibodies by the susceptible host. (Fassi-Fihri et. al, 1998). 
Virus isolation is time consuming and expensive. 
           Serogroup-specific and serotype-specific complementary DNA 
(cDNA) probes derived from different AHSV genome segments have 
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been developed to solve those problems  mentioned above. (Zientara et. 
al, 1998). 
            With  dot-blot hybridization, the minimum amount of AHSV 
RNA these cDNA probes could detect was found to be in the nanogram 
range.(Zientara et . al, 1998) . 
            This low sensitivity of recombinant DNA probes restricts their 
application  for direct detection of virus nucleic acid sequence present at 
very low amounts in biological specimens. Now, for the detection and 
differentiation of related orbiviruses including BTV and AHSV, the 
polymerase chain reaction (PCR) has  high sensitivity (Aradaib et .al, 
2003). 
              In the present study, a reproducible, sensitive, and specific RT-
PCR technology was described for detection of nine AHSV serotypes 
genomes in cell culture using primers derived from segment 3 of AHSV 
serotype 6. 
The described assay reproducibly and specifically detected AHSV RNA 
in infected cell cultures. Selection of the primers was based on 
observation that the genome segment 3-specific probe requires small 
numbers of infected cells to produce appositive hybridization signal 
compared to other nucleic acid probes used for detection of AHSV. The 
specific 240 bp PCR products, visualized on ethidium bromide –stained 
agarose gels, were obtained from all AHSV RNA samples tested. The 
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AHSV PCR assay was a simple procedure that efficiently detected all 
AHSV strains under the stringent condition used in this study. 
             This assay is easier than other molecular biological techniques, 
many of which are lengthy and cumbersome (Zientara et. al, 1995a.b). 
                The sensitivity studies indicated that this PCR protocol was 
capable of detecting 100fg of total AHSV genomic dsRNA.  
               The specific 240 bp PCR product was not amplified from high 
concentration of 1.0 ng of RNA from BTV serotype 10 under the same 
strigency condition described in this study.  
             The primer annealing and extension, the enzyme and MgCl2 
concentrations, the temperature and time for denaturation, and number of 
cycles of three temperatures in each step were very important for keeping 
sensitivity and specify of the PCR reaction. The time needed for 
amplification was approximately 4 hours.                         
For detection of African horse sickness virus (AHSV) in splenic tissues 
from infected horses, a single tube reverse transcription-polymerase chain 
reaction (RT-PCR) method was described to amplify the 1179 bp 
amplification product (the segment 7 which encodes for VP 7) (Zientara 
et al., 2004).  
        The reverse transcription followed by the polymerase chain 
reaction (RT-PCR) technique using specific primers for attenuated AHSV 
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serotype 4 segment 5 (NS1 gene) was used for detection of African horse 
sickness virus (AHSV). Using this primer pair, no RT-PCR product was 
detected from the RNA samples extracted from ten other orbiviruses 
infected cells and their virions. . (Mizukoshi et al, 1994). 
  A single primer pair which amplified a 423-bp fragment of the 
segment 8 gene which encodes the NS2 protein of AHSV, was used for 
reverse transcription-PCR (RT-PCR) to detect African horse sickness 
virus (AHSV) (Stone-Marschat et al, 1994). 
     (Koakemoer, et al., 2004) Describes the first one-day serotyping 
procedure that requires only a single RT-PCR and hybridization and 
which can identify multiple serotypes in mixed infections in one assay.    
The same region of genome segment 2 of all nine AHSV serotypes was 
amplified in a single RT-PCR. A universal primer set, designed to 
amplify the 5'-terminal 521-553bp of genome segment 2 of all of the 
1179 bp amplified product nine AHSV serotypes with one reaction, was 
used to generate serotype-specific probes from dsRNA prepared from 
infected tissue cultures or organ samples.  
  A coupled reverse transcriptase-polymerase chain reaction assay 
(RT-PCR) was developed   for the detection of African horse sickness 
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virus (AHSV). The primers which was selected used genome segment 7 
and 10 as target templates for RT-PCR. Zientara et al,.1995 )  
   Sailleau C et al., 1997 used the reverse transcription-polymerase 
chain reaction (RT-PCR) assay which was followed by dot-blot 
hybridization for detection of African horse sickness virus (AHSV); the 
primers employed amplified the S7 gene that encodes the VP7 protein. 
The RT-PCR assay was compared with virus isolation for detecting 
AHSV in blood samples form horses experimentally infected with 
AHSV-4 and AHSV 9. 
 The AHSV RT-PCR assay described using primers derived from 
segment 3 of AHSV serotype 6 to detect AHSV RNA in infected cell 
culture .The specific 890 bp PCR product was visualized on ethidium 
bromide-stained agarose gel .(Aradaib et al ., 2006).  
        In conclusion, the described AHSV RT-PCR assay, using 
primers derived from genome segment 3 of AHSV serotype 6, provides a 
simple, rapid, sensitive and diagnostic method for detection of AHSV.   
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